Evidence mapPaperPMID 41979886Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2026

Hyperactive muscle mTORC1 attenuates functional adaptations to endurance training despite alterations in mitochondrial and lipid profiles.

Hanna Kalenta, Erik D Marchant, Sean P Kilroe, Rosario Maroto, Jacquelyn T May, Vladislav Bugay, Trevor B Romsdahl, Jennifer J Linares, Mandy R Hinojosa, Zhao Lai and 2 more

Abstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hanna KalentaDepartment of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States.ORCID 0009-0000-7965-4733
Erik D MarchantDepartment of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States.ORCID 0000-0002-2222-7594
Sean P KilroeDepartment of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States.ORCID 0009-0000-9382-3783
Rosario MarotoDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States.
Jacquelyn T MayDepartment of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States.
Vladislav BugayGreehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States.
Trevor B RomsdahlDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States.ORCID 0000-0001-9075-9771
Jennifer J LinaresDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States.ORCID 0009-0009-3012-8236
Mandy R HinojosaGreehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States.
Zhao LaiGreehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States.
William K RussellDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States.ORCID 0000-0003-1931-4555
Blake B RasmussenDepartment of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States.ORCID 0000-0001-7854-5375

Funding

TISSUE CULTURE---COREP30CA054174 · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · 1991 to 2025
$17.6M
TRANSGENIC COREP30AG013319 · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · 1995 to 2025
$7.5M
Advancing Cancer Research Through Next Generation Sequencing at Mays Cancer Center of UT Health San AntonioR50CA265339 · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · 2025 to 2025
$191k
Cancer Prevention and Research Institute of Texas (CPRIT) RP190682Cancer Prevention and Research Institute of Texas (CPRIT) RP220662HHS | NIH | NIH Office of the Director (OD) 1S10 OD030311NCI NIH HHS P30 CA054174NCI NIH HHS R50 CA265339NIA NIH HHS P30 AG013319NIA NIH HHS R56 AG051267NIH HHS S10 OD030311
6 · The paper itself

Abstract

Mechanistic target of rapamycin complex I (mTORC1) is a key regulator of cell growth and metabolism, and its activity increases with aging. Hyperactivation of mTORC1 is associated with the pathology of sarcopenia and mitochondrial dysfunction. Exercise training has been shown to improve muscle quality and function in people with sarcopenia. However, it is unknown if hyperactive mTORC1 will alter exercise training-induced adaptations. In this study, we examined the effect of endurance training on muscle function and metabolism in a mouse model of hyperactive mTORC1 [DEP domain-containing protein 5 muscle-specific knockout (DEPDC5 mKO)]. After 8 wk of exercise training, DEPDC5 mKO mice had increased mitochondrial activity and tibialis anterior (TA) muscle mass, despite no change in physical function. Furthermore, DEPDC5 mKO mice had a trend for reduction in the phosphorylation of the mTORC1 downstream target, ribosomal protein S6, which may have contributed to the lack of functional adaptations. In addition, there was a reduction in triglycerides (TGs) and phosphatidylcholines (PCs) in DEPDC5 mKO mice, suggesting an increase in lipid fuel use and alterations in lipid membrane composition due to an increase in mitochondrial activity. We conclude that hyperactive mTORC1 in muscle may attenuate functional adaptations to endurance exercise training, despite increasing mitochondrial respiration and alterations in lipid metabolism.

Indexed as

Adaptation, PhysiologicalEndurance TrainingLipid MetabolismMechanistic Target of Rapamycin Complex 1MitochondriaMitochondria, MuscleMuscle, SkeletalPhysical Conditioning, AnimalAnimalsMaleMiceMice, Inbred C57BLMice, KnockoutPhosphorylationPhysical EnduranceTriglyceridesMechanistic Target of Rapamycin Complex 1TriglyceridesexercisemetabolismmitochondriamTORC1muscle

Identifiers

PMID41979886
PMCPMC13182855

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.